RUNX1 and acute myeloid leukemia: These mutations mainly interrupt the catalytic domain of DNMT3A and lead to hypomethylation of normally overexpressed hematopoietic stem cell-specific genes (such as RUNX1, ERG, MYC, and SMAD3) in AML, thereby interfering with the normal differentiation of hematopoietic stem cells.